Journal article icon

Journal article

Can levosimendan reduce ECMO weaning failure in cardiogenic shock? A cohort study with propensity score analysis.

Abstract:

Background
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been increasingly used over the last decade in patients with refractory cardiogenic shock. ECMO weaning can, however, be challenging and lead to circulatory failure and death. Recent data suggest a potential benefit of levosimendan for ECMO weaning. We sought to further investigate whether the use of levosimendan could decrease the rate of ECMO weaning failure in adult patients with refractory cardiogenic shock.

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1186/s13054-020-03122-y

Authors


More by this author
Role:
Author
ORCID:
0000-0001-9261-1682
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Primary Care Health Sciences
Role:
Author
Publisher:
BioMed Central Publisher's website
Journal:
Critical Care Journal website
Volume:
24
Article number:
442
Publication date:
2020-07-16
Acceptance date:
2020-06-29
DOI:
EISSN:
1466-609X
ISSN:
1364-8535
Pmid:
32677985
Language:
English
Keywords:
Pubs id:
1120288
Local pid:
pubs:1120288
Deposit date:
2020-08-27

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP